Loading...
Loading...
Comprehensive precision-medicine protocol addressing 36+ contributing factors to Alzheimer's disease.
88/100
Dale Bredesen
Prevention: lifelong; MCI/early AD: 6-12 months to see improvement
24 phases
3 targeted
Comprehensive precision-medicine protocol addressing 36+ contributing factors to Alzheimer's disease. Based on Dr. Bredesen's research showing reversal of early-stage AD with multi-modal approach.
Paradigm shift: Alzheimer's is not one disease but end result of 36+ factors (infections, inflammation, toxins, vascular, metabolic, trophic factor loss). Bredesen's precision medicine approach identifies individual contributors and addresses each. Case series of 100+ patients showing reversal of MCI and early AD (first time in history). Later-stage AD harder to reverse but progression can slow. Key insights: Amyloid is protective response to insults (infections, toxins, inflammation), not primary cause. Insulin resistance central (brain glucose hypometabolism, "Type 3 diabetes"). ApoE4 carriers (25% of population) at higher risk, need more aggressive prevention. Ketones provide alternative brain fuel (ketogenic diet or MCT oil). Sleep apnea massively increases risk (hypoxia, fragmented sleep prevents amyloid clearance). Oral microbiome connection (P. gingivalis found in AD brains). Homocysteine >10 doubles risk. Comprehensive approach is complex but addresses root causes. Prevention is key - protocol most effective before significant damage. Many of same factors prevent vascular dementia. ApoHealth and trained Bredesen practitioners can guide protocol. This is future of Alzheimer's treatment - precision medicine, not one drug.
About Evidence Score
The Evidence Score rates the strength of clinical and scientific evidence behind this protocol. Higher scores indicate stronger research support. This is a research tool, not medical advice.
Educational purposes only. Some alternative protocols carry serious risks. Always consult qualified healthcare professionals before beginning any treatment.